Validation of MicroRNA Biomarkers for Alzheimer's Disease in Human Cerebrospinal Fluid

Manuscript Number: 

18-0539R3

Author(s): 
Douglas Galasko, Christina A. Harrington, Jodi A. Lapidus, Babett Lind, Theresa A. Lusardi, Trevor J. McFarland, Jay I. Phillips, Joseph F. Quinn, Ursula S. Sandau, Julie A. Saugstad, Jack T. Wiedrick

Disclosures

Douglas Galasko

  • Consulting Fees:
    Consultant for vTv Pharmaceuticals; paid DSMB for Cognition Therapeutics.
    Grants
    • Agency: 
      Eli Lilly, Inc
      Dates: 
      ongoing
    • Agency: 
      Biogen, Inc
      Dates: 
      2017 - ongoing
    • Agency: 
      Genentech, Inc.
      Dates: 
      ongoing

Christina A. Harrington

  • Nothing to Disclose

Jodi A. Lapidus

  • Nothing to Disclose

Babett Lind

  • Nothing to Disclose

Theresa A. Lusardi

  • Nothing to Disclose

Trevor J. McFarland

  • Nothing to Disclose

Jay I. Phillips

  • Nothing to Disclose

Joseph F. Quinn

  • Nothing to Disclose
    Grants
    • Agency: 
      Abbvie,Sanofi, Roche

Ursula S. Sandau

  • Nothing to Disclose

Julie A. Saugstad

  • Nothing to Disclose

Jack T. Wiedrick

  • Nothing to Disclose